Kevin D Freeman Galectin Therapeutics Inc (GALT) insider trading activity

Kevin D Freeman is of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 55,269 shares of GALT, which is worth approximately $303,979. The most recent transaction as insider was on Dec 23, 2025, when has been sold 5,500 shares (Common Stock) at a price of $3.55 per share, resulting in proceeds of $19,525. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.3K

11.05% 3M change

23.45% 12M change

Total Value Held $303,979

KEVIN D FREEMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 23 2025	BUY Open market or private purchase	$19,525 $3.55 p/Share	5,500 Added 9.05%	55,269 Common Stock
Jul 17 2025	BUY Open market or private purchase	$14,500 $2.9 p/Share	5,000 Added 9.13%	49,769 Common Stock
Dec 24 2024	BUY Open market or private purchase	$8,100 $0.81 p/Share	10,000 Added 18.26%	44,769 Common Stock
Oct 17 2024	BUY Open market or private purchase	$3,432 $2.64 p/Share	1,300 Added 3.6%	34,769 Common Stock
Oct 16 2024	BUY Open market or private purchase	$13,500 $2.7 p/Share	5,000 Added 13.0%	33,469 Common Stock
Jun 20 2024	BUY Open market or private purchase	$5,950 $2.38 p/Share	2,500 Added 8.07%	28,469 Common Stock
Apr 22 2024	BUY Open market or private purchase	$7,450 $2.98 p/Share	2,500 Added 8.78%	25,969 Common Stock

KDF

Kevin D Freeman

Norcross, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Value

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

Operation

Value

Type

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT

Account